Samsung Bioepis Co Ltd
General
Total Cases41
Active Cases5
Patents14
Ratings
Experience
Grade
Trend
DCT
L1
D
PTAB
L5
A
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 09/16/24 | ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., [175] Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, 261 Notice of Appeal filed by Formycon AG, [176] Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
| 09/16/24 | ORDER of USCA for the Federal Circuit as to [259] Notice of Appeal filed by Samsung Bioepis Co., Ltd., [190] Notice of Appeal filed by BIOCON BIOLOGICS INC., Mylan Pharmaceuticals Inc., [258] Notice of Appeal filed by Samsung Bioepis, CO., LTD., 175 Notice of Appeal, filed by Samsung Bioepis, CO., LTD., [203] Notice of Appeal, filed by Formycon AG, [261] Notice of Appeal filed by Formycon AG, 176 Notice of Appeal, filed by Samsung Bioepis Co., Ltd. (snc) Modified to adjust filing date on 9/16/2024 (snc). (Entered: 09/16/2024) | |
| 09/13/24 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # [1] Exhibit Ex. A, # [2] Exhibit Ex. B, # [3] Exhibit Ex. C, # [4] Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) | |
| 09/13/24 | MOTION for Status Conference by Amgen, Inc., Celltrion, Inc., Formycon AG, Samsung Bioepis, CO., LTD.,. (Attachments: # [1] Exhibit Ex. A, # [2] Exhibit Ex. B, # [3] Exhibit Ex. C, # [4] Exhibit Ex. D)Associated Cases: 1:24-md-03103-TSK-JPM et al.(Gottlieb, Max) (Entered: 09/13/2024) | |
| 09/03/24 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (jaa) (Entered: 09/03/2024) | |
| 09/03/24 | ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) | |
| 09/03/24 | ORDER GRANTING MOTIONS TO WITHDRAW. For good cause, they are GRANTED (ECF Nos. 323 , 324 ). Renee M. Griffin and Yi Zhang shall be TERMINATED as counsel of record. Signed by Chief District Judge Thomas S. Kleeh on 09/03/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 09/03/2024) | |
| 09/03/24 | SO ORDERED, re 79 Stipulation and Order of Dismissal Without Prejudice. ***Civil Case Terminated.. Signed by Judge Gregory B. Williams on 9/3/24. (jaa) (Entered: 09/03/2024) | |
| 08/30/24 | STIPULATION of Dismissal without prejudice by Alexion Pharma International Operations Ltd., Alexion Pharmaceuticals, Inc.. (Silver, Daniel) (Entered: 08/30/2024) | |
| 08/30/24 | MOTION to Withdraw as Attorney YI ZHANG'S MOTION TO WITHDRAW AS COUNSEL by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM et al.(Pogue, David) (Entered: 08/30/2024) |